Position in SUPN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,116
-$569 QoQ
Shares Held
110
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#280
of 331 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MATHER GROUP, LLC. holds $313,557 across 11 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
8,368 | $132,883 | |
| 2 | ZTS |
Zoetis Inc.
|
987 | $70,925 | |
| 3 | HLN |
Haleon plc
|
5,433 | $50,689 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
158 | $26,629 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
136 | $15,087 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
110 | $5,116 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
145 | $4,912 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
148 | $3,642 |
All Filings in SUPN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,116 | 110 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,685 | 110 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $12,903 | 270 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $8,842 | 270 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,977 | 110 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,429 | 110 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $6,687 | 250 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $8,527 | 250 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||